Vanguard Group
ASXC

Vanguard Group’s Asensus Surgical, Inc. ASXC Stock Holding History

Vanguard Group’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,588,282
Closed -$3.86M – 4414
2024
Q2 		$3.86M Hold
11,588,282
– – ﹤0.01% 3361
2024
Q1 		$2.67M Buy
11,588,282
+1,122
+0% +$326 ﹤0.01% 3502
2023
Q4 		$3.7M Buy
11,587,160
+193,703
+2% +$49.9K ﹤0.01% 3396
2023
Q3 		$3.08M Hold
11,393,457
– – ﹤0.01% 3444
2023
Q2 		$5.75M Sell
11,393,457
-43,403
-0.4% -$25.9K ﹤0.01% 3239
2023
Q1 		$7.53M Hold
11,436,860
– – ﹤0.01% 3101
2022
Q4 		$3.97M Buy
11,436,860
+5,068
+0% +$2.06K ﹤0.01% 3411
2022
Q3 		$5.13M Buy
11,431,792
+575,904
+5% +$300K ﹤0.01% 3312
2022
Q2 		$4.32M Buy
10,855,888
+715,839
+7% +$319K ﹤0.01% 3451
2022
Q1 		$6.36M Sell
10,140,049
-1,027,932
-9% -$792K ﹤0.01% 3401
2021
Q4 		$12.4M Buy
11,167,981
+77,444
+0.7% +$120K ﹤0.01% 3104
2021
Q3 		$20.5M Sell
11,090,537
-297,069
-3% -$667K ﹤0.01% 2852
2021
Q2 		$36.1M Buy
11,387,606
+5,254,805
+86% +$13.1M ﹤0.01% 2540
2021
Q1 		$19.9M Buy
6,132,801
+3,973,807
+184% +$14.4M ﹤0.01% 2787
2020
Q4 		$1.35M Buy
2,158,994
+333,290
+18% +$152K ﹤0.01% 3755
2020
Q3 		$634K Buy
1,825,704
+1,176,230
+181% +$455K ﹤0.01% 3766
2020
Q2 		$351K Sell
649,474
-61,131
-9% -$29.5K ﹤0.01% 3845
2020
Q1 		$250K Sell
710,605
-32,715
-4% -$34.2K ﹤0.01% 3823
2019
Q4 		$1.09M Sell
743,320
-17,680
-2% -$61.4K ﹤0.01% 3619
2019
Q3 		$6.13M Buy
761,000
+50,892
+7% +$692K ﹤0.01% 3059
2019
Q2 		$12.6M Buy
710,108
+76,240
+12% +$1.67M ﹤0.01% 2728
2019
Q1 		$19.6M Buy
633,868
+39,003
+7% +$1.31M ﹤0.01% 2514
2018
Q4 		$17.5M Sell
594,865
-55,524
-9% -$2.52M ﹤0.01% 2507
2018
Q3 		$49M Buy
650,389
+77,161
+13% +$5.22M ﹤0.01% 2153
2018
Q2 		$32.5M Buy
573,228
+140,628
+33% +$5.12M ﹤0.01% 2347
2018
Q1 		$9.56M Buy
432,600
+30,194
+8% +$691K ﹤0.01% 2845
2017
Q4 		$10.1M Buy
402,406
+159,571
+66% +$4.91M ﹤0.01% 2812
2017
Q3 		$4.51M Buy
242,835
+76,894
+46% +$895K ﹤0.01% 3158
2017
Q2 		$1.53M Sell
165,941
-20,445
-11% -$194K ﹤0.01% 3461
2017
Q1 		$2.93M Buy
186,386
+3,668
+2% +$63.6K ﹤0.01% 3260
2016
Q4 		$3.09M Buy
182,718
+12,379
+7% +$254K ﹤0.01% 3217
2016
Q3 		$3.74M Buy
170,339
+15,286
+10% +$279K ﹤0.01% 3142
2016
Q2 		$2.46M Buy
155,053
+15,982
+11% +$502K ﹤0.01% 3299
2016
Q1 		$7.68M Buy
139,071
+25,463
+22% +$1.09M ﹤0.01% 2749
2015
Q4 		$3.66M Buy
113,608
+6,455
+6% +$208K ﹤0.01% 3124
2015
Q3 		$3.15M Buy
107,153
+16,169
+18% +$600K ﹤0.01% 3175
2015
Q2 		$3.55M Buy
90,984
+37,002
+69% +$1.7M ﹤0.01% 3172
2015
Q1 		$2.06M Buy
53,982
+11,212
+26% +$423K ﹤0.01% 3401
2014
Q4 		$1.62M Buy
42,770
+5,318
+14% +$219K ﹤0.01% 3360
2014
Q3 		$2.12M Buy
37,452
+1,577
+4% +$85K ﹤0.01% 3236
2014
Q2 		$2.35M Buy
+35,875
New +$2.07M ﹤0.01% 3192

Other funds holding ASXC

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Group's ASXC Position: Q3 2024 in Review

Vanguard Group sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 11,588,282 shares — an estimated $3.86M sold.

Vanguard Group first reported a position in ASXC in Q2 2014 and held it in 41 quarters. The position peaked at $49M in Q3 2018. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • Vanguard Group reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • Vanguard Group sold 11,588,282 Asensus Surgical, Inc. shares in Q3 2024, an estimated $3.86M.
  • Vanguard Group first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 41 quarters.
  • Vanguard Group's Asensus Surgical, Inc. position peaked at $49M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Vanguard Group's 13F filing for Q3 2024, filed 13 Nov 2024.